Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: A randomized study

Journal of Child Neurology

Volumn 27, Issue 3, 2012, Pages 304-309

  Hagebeuk, Eveline E O ^a   Duran, Marinus ^a   Koelman, Johannes H T M ^a   Abeling, Nicolaas G G M ^a   Vyth, Arno ^a   Poll The, Bwee Tien ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

5 methyltetrahydrofolate; folate; folinic acid; Hand Apraxia Scale; Rett Motor Behavior Assessment; Rett syndrome; vitamin B12

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; CYANOCOBALAMIN; FOLIC ACID; FOLINIC ACID; PLACEBO;

ADULT; ARTICLE; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HUMAN; LONG TERM CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RETT SYNDROME; SCHOOL CHILD; SCORING SYSTEM; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; WELLBEING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HUMANS; LEUCOVORIN; LINEAR MODELS; LONGITUDINAL STUDIES; METHYL-CPG-BINDING PROTEIN 2; MUTATION; NEUROLOGIC EXAMINATION; RETT SYNDROME; TETRAHYDROFOLATES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858639510     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811417184     Document Type: Article

References (20)

1. Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden. Eur J Paediatr Neurol. 2002;6:293-297. (Pubitemid 36267302)
2. Jian L, Nagarajan L, de Klerk N, Ravine D, Christodoulou J, Leonard H. Seizures in Rett syndrome: an overview from a one-year calendar study. Eur J Paediatr Neurol. 2007;1:310-317. (Pubitemid 47194449)
3. Glaze DG, Percy AK, Skinner S, et al. Epilepsy and the natural history of Rett syndrome. Neurology. 2010;74:909-912.
4. Cass H, Reilly S, Owen L, et al. Findings from a multidisciplinary clinical case series of females with Rett syndrome. Dev Med Child Neurol. 2003;45:325-337. (Pubitemid 36469392)
5. Neul JL, Fang P, Barrish J, et al. Specific mutations in Methyl- CpG-Binding Protein 2 confer different severity in Rett syndrome. Neurology. 2008;70:1313-1321. (Pubitemid 351550354)
6. Ramaekers VT, Hansen SI, Holm J, et al. Reduced folate transport to the CNS in female Rett patients. Neurology. 2003;61:506-515. (Pubitemid 37025368)
7. Ormazabal A, Artuch R, Vilaseca MA, Aracil A, Pineda M. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid. Neuropediatrics. 2005;36:380-385. (Pubitemid 43162349)
8. Temudo T, Rios M, Prior C, et al. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment. Brain Dev. 2009;31:46-51.
9. Huang L, Zhang T, Hayakawa T, Tsuge H. Assays of methylene- tetrahydrofolate reductase and methionine synthase activities by monitoring 5-methyltetrahydrofolate and tetrahydrofolate using high-performance liquid chromatography with fluorescence detection. Anal Biochem. 2001;299:253-259. (Pubitemid 34053418)
10. Hagberg B, Witt-Engerstróm I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet. 1986;24(Suppl):47-59. (Pubitemid 16081494)
11. Schanen C, Houwink EJ, Dorrani N, et al. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet A. 2004;126A:129-140. (Pubitemid 38445468)
12. Burd L, Cook J, Randall T. The hand apraxia scale. Percept Mot Skills. 1990;70:219-224. (Pubitemid 20165716)
13. Ellaway C, Wiliams K, Leonard H, Higgins G, Wilcken B, Christodoulou J. Rett syndrome: randomized controlled trial of L-carnitine. J Child Neurol. 1999;14:162-167. (Pubitemid 29146696)
14. FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov Disord. 1990;5:195-202. (Pubitemid 20311768)
15. Freeman JM, Vining EP, Cost S, Singhi P. Does carnitine administration improve the symptoms attributed to anticonvulsant medications? A double-blinded, crossover study. Pediatrics. 1994;93:893-895. (Pubitemid 24163333)
16. van der Windt DA, Koes BW, Deville W, Boeke AJ, de Jong BA, Bouter LM. Effectiveness of corticosteroid injections versus physiotherapy for treatment of painful stiff shoulder in primary care: randomised trail. BMJ. 1998;317:1292-1296. (Pubitemid 28502415)
17. Hagebeuk EE, Koelman JH, Duran M, Abeling NG, Vyth A, Poll- The BT. Clinical and electroencephalographic effect of folinic acid treatment in Rett syndrome patients. JChild Neurol. 2011;26:718-723.
18. GlazeDG, PercyAK,Motil KJ, et al.Astudy of the treatment of Rett syndrome with folate and betaine. J Child Neurol. 2009;24:551-556.
19. Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low functioning autism with neurological deficits. Neuropediatrics. 2007;38:276-281. (Pubitemid 351737986)
20. Garzia-Cazorla A, Quadros EV, Nascimento A, et al. Mitochondrial diseases associated with cerebral folate deficiency. Neurology. 2008;70:1360-1362. (Pubitemid 351550342)